Rare diseases
Investigational molecules
Locations
296 conditions with trials, the busiest first
591 trials across Europe, recruiting first
Short-course (7‑day) versus standard 14‑day ciprofloxacin treatment for men with serious urinary tract infection
BelgiumLong-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
BelgiumBelzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy
CzechiaFrexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients
AustriaA study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.
BelgiumA study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
BelgiumA study to evaluate the efficacy and safety of obinutuzumab compared to prednisolone in adults with newly onset minimal change disease
AustriaA study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer
GermanyA study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer
BelgiumComparing pivmecillinam and gentamicin with standard treatments for hospitalized adults with complicated urinary tract infections
DenmarkA study to compare the effects of BI 690517 and spironolactone on kidney function in patients with heart failure, cardiovascular disease, or chronic kidney disease
The NetherlandsEffect of sodium hydrogen carbonate on kidney health in critically ill patients with metabolic acidosis and acute kidney injury
GermanyThe therapies tested most often in Renal and urinary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
